Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 744.37

+1.0%

10:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2192)	9/11/2017 10:46:03 AM
From: Miljenko Zuanic	Read Replies (1) of 3559

Surprice???!!! finance.yahoo.com So, what trigger SNY rush for more REGN shares? Obviously, in subgroup of ~30% subjects in asthma P3 trial (e<150) Dupi was not as effective as on rest of 70%, mostly as neutral, or there was INBALANCE in placebo/drug e<150 sub-group? That Dupi is not as effective in non-allergic condition is no secret, but that is worse???? In my view, and I did mentioned early, Eylea growth for next 5 years support REGN ~50B MC, all rest is +++. So, severe correction is...???????? ...., bits me!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next